Search for: "Mylan Pharmaceuticals"
Results 401 - 420
of 739
Sorted by Relevance
|
Sort by Date
26 Jun 2012, 11:09 am
Mylan Pharmaceuticals manufacturers generic fentanyl patches, using a "matrix design" in which the fentanyl is in the patch adhesive. [read post]
10 Jul 2012, 5:49 pm
In the litigation, our firm represented Metrics, Inc., doing business as Coastal Pharmaceuticals, and Mylan Pharmaceuticals Inc., which markets the generic product. [read post]
23 Jun 2010, 10:28 pm
Mylan Inc. et al. [read post]
26 Jun 2012, 11:09 am
Mylan Pharmaceuticals manufacturers generic fentanyl patches, using a "matrix design" in which the fentanyl is in the patch adhesive. [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
1 Sep 2014, 7:04 am
. * Letter from AmeriKat: Judge Koh declares Takeda takes it too far with Mylan Dexilant declaration: The AmeriKat is back with a case review of Takeda Pharmaceutical Co., Ltd. et al v Mylan Inc. et al (here). [read post]
17 Apr 2009, 12:00 am
Ltd. sues 11 generics companies over Levaquin patents (Law 360) Lexapro (Escitalopram) – Netherlands District court invalidates Lundbeck’s patent EP ‘066 (IPKat) Lexapro (Escitalopram) - Baldwin’s rules explained (The SPC Blog) Lexapro (Escitalopram) – federal district Judge agrees to determine whether Forest Laboratories destroyed key documents (Law 360) Pegasys (PEG interferon alfa 2a) – Roche wins post grant opposition against Wockhardt… [read post]
2 Feb 2011, 3:52 am
Highlights this week included: India, South Africa gain from J&J generic deal, Patent Pool loses out (Spicy IP) (KEI) Advair (Fluticasone propionate, Salmeterol) – Netherlands: GSK reverse on Dutch Advair patent and SPC (The SPC Blog) (The SPC Blog) (Kluwer Patent Blog) Brazilian Attorney General of the Union restricts ANVISA’s role in pharmaceutical patent review (PatentlyBIOtech) Please join the discussion by adding your comments on any of these stories, and please do let… [read post]
9 Sep 2008, 1:28 am
District Court for the Southern District of New York finding that Mylan and Esteve did not infringe on the same patents. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on… [read post]
25 Jul 2008, 2:11 am
Mylan Laboratories, Inc., 520 F.3d 1358, 1364 (Fed. [read post]
21 Nov 2012, 5:00 am
Mylan Inc., No. 12-11684, 2012 WL 5300721, at *8 (E.D. [read post]
5 Dec 2008, 1:00 pm
(Holman's Biotech IP Blog) IP and genetically modified organisms: a fateful combination, activists say (Intellectual Property Watch) Australia: Gene patent delays diagnosis and treatment for babies with severe form of epilepsy: (Techdirt) Brazil: Brazilian draft law would curb expanded patents on pharmaceuticals (Intellectual Property Watch) (IP tango) EU: European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat)… [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor (IPKat) (The SPC blog) Sustiva (Efavirenz) - Brazil: Compulsory licensed Efavirenz will be manufactured by public Brazilian laboratories by end of 2008 (IP tango) General A patent question of patents: Prof T Pogge's 'Health Impact Fund' alternative licensing system (Patent… [read post]
7 Sep 2006, 3:46 pm
Mylan Laboratories, Inc., et al. [read post]
3 Aug 2013, 6:35 am
Mylan Laboratries (pharma company) is at a distant second spot, with supplies worth $ 45 million. [read post]
5 May 2010, 4:46 am
Mylan Pharmaceuticals Inc. et al. [read post]
12 Jul 2010, 9:40 am
Mylan Pharmaceuticals Inc., C.A. 09-184-... [read post]
24 Apr 2024, 4:52 am
For example, Mylan and Mallinckrodt settled significant cases alleging Medicaid rebate fraud brought by our whistleblower clients. [read post]
